ArticleOdontology2026
Molecular mechanism by which mir-153-3p attenuates pulpitis in human deciduous teeth via PTEN-targeted suppression of inflammation and oxidative stress.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study characterized the expression profile of miR-153-3p in deciduous pulpitis in children, validated its role in regulating inflammation, oxidative stress, and apoptosis via PTEN targeting, and evaluated its biomarker and therapeutic potential. In a prospective design, pulp tissue was collected from 180 children with deciduous-tooth pulpitis (mild, moderate, or severe) and 180 caries-free controls. qRT-PCR was used to quantify miR-153-3p and PTEN expression, VAS pain scores were recorded, and ROC analysis was performed. An LPS-induced inflammatory model (5 µg/mL, 24 h) was established in human dental pulp stem cells, which were transfected with miR-153-3p mimic or PTEN overexpression plasmid. Cell viability, apoptosis, inflammatory cytokines, and oxidative stress markers were subsequently assessed, and correlations among miR-153-3p, VAS, and PTEN were evaluated. miR-153-3p was significantly downregulated in inflamed pulp and inversely correlated with disease severity and VAS score (r = - 0.323, P < 0.001), with an ROC AUC of 0.814. LPS suppressed miR-153-3p and elevated PTEN in a concentration- and time-dependent manner. miR-153-3p upregulation restored viability, reduced apoptosis, decreased cytokine release, increased SOD activity, and lowered MDA content. Dual-luciferase assays confirmed PTEN as a direct target, and PTEN overexpression reversed the protective effects of miR-153-3p. These findings indicate that miR-153-3p downregulation is associated with inflammation severity, and that miR-153-3p attenuates LPS-induced cellular responses by inhibiting PTEN. Its utility in assessing tissue inflammation and potential as a therapeutic target warrant further in vitro and in vivo validation.
Indexed as
Identifiers
42380708What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.